Intuitive Surgical (ISRG) is currently showing mixed signals in its technical indicators. The stock's Relative Strength Index (RSI) is at 35.19, indicating it is in oversold territory, which could signal a potential rebound. However, the Moving Average Convergence Divergence (MACD) is negative, suggesting bearish momentum in the short term.
ISRG has a strong fundamental outlook, with a market cap of $204.14 billion and a leadership position in robotic surgery. The company has shown consistent revenue growth, with a 24.9% year-over-year increase in its latest quarter. Analysts maintain a "Strong Buy" rating, with a mean target price of $642.40, indicating a potential upside of 13.3% from current levels.
Recent news highlights ISRG's dominance in the medical equipment industry, with positive sentiment around its da Vinci Surgical System and recurring revenue model. Analysts remain bullish, with 18 "Strong Buy" ratings out of 27.
Based on the analysis, ISRG is expected to trade between $494 and $510 next week. The stock is likely to experience short-term volatility but remains a strong long-term investment. Buy recommendation with a target price of $494 and a stop-loss at $484.
The price of ISRG is predicted to go up -5.23%, based on the high correlation periods with BFC. The similarity of these two price pattern on the periods is 98.63%.
ISRG
BFC
Year
ISRG Price Forecast($)
Potential Return(%)
2025
610.000
13.960
2026
700.000
22.130
2027
750.000
30.860
2028
850.000
48.300
2029
850.000
48.300
2030
1,200.000
109.370
Intuitive is launching its next-generation platform in 2024, which should give significant momentum to system placements in the next few years.
Intuitive Surgical is enjoying tremendous success in general surgery, which is now its highest-volume surgical area. The opportunity is particularly attractive internationally.
Intuitive's foray into bronchoscopy shows the company isn't resting on its laurels and is willing to look in other areas in need of robotic assistance.
Baird
2025-03-18
Price Target
$707 → $600
Upside
+23.98%
Truist Securities
2025-03-17
Price Target
$666 → $605
Upside
+23.77%
Truist Securities
2025-01-24
Price Target
$640 → $666
Upside
+14.03%